GENOCEA BIOSCIENCES INC's ticker is GNCA and the CUSIP is 372427401. A total of 32 filers reported holding GENOCEA BIOSCIENCES INC in Q1 2020. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $50,000 | +35.1% | 40,069 | +25.3% | 0.00% | – |
| Q4 2021 | $37,000 | -9.8% | 31,981 | +49.4% | 0.00% | – |
| Q3 2021 | $41,000 | -14.6% | 21,405 | +3.4% | 0.00% | – |
| Q2 2021 | $48,000 | -14.3% | 20,705 | 0.0% | 0.00% | – |
| Q1 2021 | $56,000 | +30.2% | 20,705 | +15.5% | 0.00% | – |
| Q4 2020 | $43,000 | +34.4% | 17,921 | +27.8% | 0.00% | – |
| Q3 2020 | $32,000 | 0.0% | 14,021 | +0.3% | 0.00% | – |
| Q2 2020 | $32,000 | +33.3% | 13,980 | 0.0% | 0.00% | – |
| Q1 2020 | $24,000 | – | 13,980 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 7,225,676 | $12,428,000 | 0.65% |
| FNY Investment Advisers, LLC | 300,000 | $516,000 | 0.39% |
| DAFNA Capital Management LLC | 542,564 | $933,000 | 0.39% |
| Polaris Venture Management Co. V, L.L.C. | 246,078 | $423,000 | 0.38% |
| BVF INC/IL | 2,100,305 | $3,613,000 | 0.34% |
| SABBY MANAGEMENT, LLC | 440,274 | $757,000 | 0.32% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 711,552 | $1,224,000 | 0.22% |
| Endurant Capital Management LP | 264,307 | $455,000 | 0.21% |
| Johnson & Johnson Innovation - JJDC, Inc. | 143,964 | $248,000 | 0.14% |
| Alyeska Investment Group, L.P. | 1,497,500 | $2,576,000 | 0.05% |